Tirzepatid

Dual GLP-1/GIP receptor agonist for metabolic research.

Dosages

Vial

99,90 €incl. VAT / 1 Vial

In stock

Payment by bank transfer

Verified purity
Every batch is analysed for identity and purity before it ships.
Discreet packaging
Plain outer packaging with no product details visible from the outside.
Tracked delivery
Dispatch within one working day with tracked shipping across Europe.

For research purposes only. Not intended for human consumption. For use by professionals only.

Description

Tirzepatide is a next-generation incretin peptide that acts as a dual agonist at both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism is studied for synergistic effects on glucose metabolism, satiety signalling and body composition, positioning it as a key reference compound in metabolic and endocrine research. Supplied as a sterile lyophilised vial; reconstitute with bacteriostatic water and store the reconstituted solution refrigerated.

Storage and handling

Keep the sealed vial refrigerated between 2 and 8 °C and away from direct light. Do not freeze unless your protocol requires it.

Once reconstituted, keep the vial sealed and refrigerated, and aliquot rather than warming and cooling the same container repeatedly. Note the reconstitution date on the label.

Most products in the range ship as a lyophilised powder and need bacteriostatic water before use, which we stock separately.